the study of utility and safety for robotassisted laparoscopic hysterectomy and pelvic lymphadenectomy using da Vinci S surgical system
Not Applicable
- Conditions
- terine body cancer and uterine cervical cancer
- Registration Number
- JPRN-UMIN000009653
- Lead Sponsor
- Tohoku University Hospital
- Brief Summary
We performed ten operation using Da Vinci Surgical system. We found little hemorrhage and short stay at hospital, but there was no significant result because of small numbers of cases. In addition, there were no changes about the complications of during and after surgery, which were injury for tissues, infection, hernia, thrombosis, pain, etc. Meanwhile, operation time was prolonged about one to two hours.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
bad general condition (performance status 2-4)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie reduced intraoperative hemorrhage in robotic-assisted hysterectomy for cervical cancer?
How does robotic-assisted pelvic lymphadenectomy compare to traditional laparoscopic methods in postoperative complication rates for uterine body cancer?
Which biomarkers correlate with shorter hospital stays after da Vinci S hysterectomy in early-stage cervical cancer patients?
What are the long-term adverse event profiles of da Vinci S pelvic lymphadenectomy compared to open surgery in uterine cancer?
Are there alternative robotic surgical systems to da Vinci S for treating uterine body and cervical cancers with improved efficiency?